Fred Ghanem has joined Sunresin as Vice President of Life Science division managing the American market

We are excited to announce that Fred Ghanem has joined Sunresin as Vice President of Life Science division managing the American market. Fred has 25 years experience in Ion Exchange Resins, adsorbents and specialty resins and 4 years in catalysis. With a Master of Science in Chemical Engineering and Biotechnology and a PhD in Chemical Engineering, expected 2023, Fred is a great asset that will help the company to grow substantially in the Life Science market.

With his last 7 years' experience managing the Bioprocessing market in the US, Fred has a deep knowledge of the market and will be supporting the expansion of Sunresin in the Americas.

1- Sunresin offers the widest scope of resins for the Life Science applications, including resins for purification of small and large molecules, from analytical to industrial applications. Sunresin’s portfolio of chemistries and functionalities includes the following: Ion exchange, HIC, size exclusion, affinity resins (IDA, NTA, Protein A, Heparin, and Oligo DT), reverse phase, resins for oligo and peptide synthesis, microcarriers for cell culture, magnetic particles, APIs and enzyme carriers. Sunresin is a one stop resin shop for all the customers’ application needs.

2- Sunresin is a global leading company in the resin manufacture with intention to expand its presence in Europe and the Americas by hiring top talents.

3- Sunresin prides itself with its state-of-the-art manufacturing plants operating in GMP like conditions, great product reproducibility and quality, short lead times, and pa full regulatory team.

4- Sunresin has a high number of R&D professionals to support the technology transfer, innovation, customization, and technical support to meet customers' needs.

Welcome on board Fred!

Please reach Fred at fred.ghanem@sunresin.com.